Trade Pluri Inc. - PLUR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.1660 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024151% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001929% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5.397 |
| Open | 5.297 |
| 1-Year Change | 760.18% |
| Day's Range | 5.277 - 5.377 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 15, 2024 | 5.2770 | -0.0200 | -0.38% | 5.2970 | 5.3770 | 5.0770 |
| Nov 14, 2024 | 5.3970 | -0.0100 | -0.18% | 5.4070 | 5.6170 | 5.0570 |
| Nov 13, 2024 | 5.8270 | 0.1200 | 2.10% | 5.7070 | 6.0370 | 5.4470 |
| Nov 12, 2024 | 5.4270 | 0.3100 | 6.06% | 5.1170 | 5.9570 | 4.9370 |
| Nov 11, 2024 | 4.9670 | 0.7500 | 17.79% | 4.2170 | 5.1570 | 4.2170 |
| Nov 8, 2024 | 4.3970 | 0.0000 | 0.00% | 4.3970 | 4.6470 | 4.2170 |
| Nov 7, 2024 | 4.3770 | -0.2100 | -4.58% | 4.5870 | 4.7570 | 4.2770 |
| Nov 6, 2024 | 4.4070 | 0.0100 | 0.23% | 4.3970 | 4.7970 | 4.2970 |
| Nov 5, 2024 | 4.2370 | -0.3700 | -8.03% | 4.6070 | 4.6470 | 4.0570 |
| Nov 4, 2024 | 4.4970 | -0.1700 | -3.64% | 4.6670 | 4.7970 | 4.1370 |
| Nov 1, 2024 | 4.4470 | -0.2200 | -4.71% | 4.6670 | 4.8070 | 4.1970 |
| Oct 31, 2024 | 4.8570 | 0.1400 | 2.97% | 4.7170 | 4.8970 | 4.3870 |
| Oct 30, 2024 | 4.3970 | 0.0300 | 0.69% | 4.3670 | 4.6470 | 4.1870 |
| Oct 29, 2024 | 4.0770 | -0.2000 | -4.68% | 4.2770 | 4.4570 | 3.9670 |
| Oct 28, 2024 | 3.9370 | -0.1800 | -4.37% | 4.1170 | 4.3270 | 3.9370 |
| Oct 25, 2024 | 4.3270 | 0.1800 | 4.34% | 4.1470 | 4.4470 | 4.1470 |
| Oct 24, 2024 | 4.2570 | 0.1600 | 3.91% | 4.0970 | 4.3570 | 3.9370 |
| Oct 23, 2024 | 4.1270 | -0.2200 | -5.06% | 4.3470 | 4.4870 | 4.0370 |
| Oct 22, 2024 | 4.4470 | -0.0100 | -0.22% | 4.4570 | 4.5870 | 4.4470 |
| Oct 21, 2024 | 4.5170 | 0.0000 | 0.00% | 4.5170 | 4.7970 | 4.5170 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Pluri Inc. Company profile
About Pluristem Therapeutics Inc.
Pluristem Therapeutics Inc. is a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The Company's lead indications are critical limb ischemia (CLI), recovery after surgery for femoral neck fracture and acute radiation syndrome. Its operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. The Company's products include PLX-PAD and PLX R18. The Company's PLX cells are adherent stromal cells (ASCs) that are expanded using a three dimensional (3D) process. The system utilizes a synthetic scaffold to create an artificial 3D environment where placental-derived stromal cells can grow. The Company's PLX products are administered using a standard needle and syringe. The Company's PLX products are in clinical-stage development for multiple indications, such as cardiovascular, orthopedic, pulmonary and women's health diseases.
Financial summary
BRIEF: For the six months ended 31 December 2021, Pluristem Therapeutics Inc. revenues was not reported. Net loss increased 6% to $22.4M. Higher net loss reflects General and administrative expenses increase of 30% to $4.8M (expense), Stock-based Compensation in SGA increase of 9% to $4.6M (expense), Research & Development Expense decrease of 75% to $72K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.82 to -$0.70.
Equity composition
Common Stock $0.00001 Par, 01/13, 100M auth., 58,333,206 issd. Insiders control 11.74%. IPO: NA. 11/07,1-for-200 reverse stock split. 11/07, Name changed from Pluristem Life Systems, Inc. 12/07, Exchanged changed from OTC Bulletin Board to NASDAQ.
| Industry: | Biotechnology & Medical Research (NEC) |
Matam Park Building 5
HAIFA
3508409
IL
News
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024
US elections: Trump leads the polls, but tariff talk spooks investors
As the US elections get closer we look at how Trump’s tariff plans could affect markets.
15:02, 22 October 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com